Braskem Sa ( (BAK) ) has released its Q1 earnings. Here is a breakdown of the information Braskem Sa presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Braskem S.A. is a leading petrochemical company in the Americas and a global leader in biopolymers, primarily engaged in the production of resins and chemicals. In its latest earnings report for the first quarter of 2025, Braskem reported a significant increase in Recurring EBITDA to US$224 million, marking a 121% rise from the previous quarter. The company also achieved a net profit of R$698 million attributable to shareholders.
Key financial highlights include a 76% increase in Recurring EBITDA for the Brazil/South America segment, which accounted for 78% of the company’s consolidated segment EBITDA. The United States and Europe segment saw an 11% rise in sales volume, leading to a Recurring EBITDA of US$20 million. In Mexico, despite a 5% drop in sales volume, the segment’s Recurring EBITDA grew by 6%, driven by a 4% increase in the PE spread.
Braskem’s consolidated revenue for the quarter was US$3.3 billion, with a gross debt balance of US$8.6 billion. The company maintained a cash level of approximately US$2.0 billion, sufficient to cover debt maturities for the next 33 months. The average debt maturity is around 9 years, with 68% of maturities concentrated from 2030 onwards.
Looking ahead, Braskem’s management remains focused on operational efficiency and strategic investments, including the completion of an ethane import terminal in Mexico. The company aims to leverage its strong financial position to navigate market uncertainties and capitalize on growth opportunities in the global petrochemical industry.